In this edition:
BE OPTIMAL: dual IL-17A/17F targeting with bimekizumab efficacious for PsA
Guselkumab drives pain relief independently from inflammation
Methotrexate treatment may delay RA onset in patients with arthralgia
GLORIA finds low-dose adjunct corticosteroids efficacious for established RA
Risk of MACE with tofacitinib in RA
Sarilumab efficacious for steroid-refractory polymyalgia rheumatica
PAISLEY assesses deucravacitinib for SLE
Use of telemedicine for follow-up of lupus nephritis
Increased enteric permeability after FMT treatment failure in PsA
Trends in hospitalisation for opportunistic infections in patients with IJD
Please login below to download this issue (PDF)